Thus, we hypothesized that STAT1 signaling pathway may also be a key regulator of inflammation in non-alcoholic steatohepatitis (NASH) induced via testosterone deficiency and HFHF diet. The gene discussed is STAT1; the disease is metabolic dysfunction-associated steatohepatitis.